کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
4221471 | 1281623 | 2015 | 6 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Fenoldopam for the prevention of contrast-induced nephropathy (CIN)—do we need more trials? A meta-analysis
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
رادیولوژی و تصویربرداری
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Fenoldopam for the prevention of contrast-induced nephropathy (CIN)—do we need more trials? A meta-analysis Fenoldopam for the prevention of contrast-induced nephropathy (CIN)—do we need more trials? A meta-analysis](/preview/png/4221471.png)
چکیده انگلیسی
We conducted a pooled analysis of clinical trials comparing intravenous Fenoldopam (FP) with Saline/Placebo/N-acetyl cysteine (NAC) for the prevention of contrast-induced nephropathy (CIN). Five studies were eligible. Quantitative analyses were done with Review Manager (RevMan version 5.2.). A total of 85 out of 353 patients in Fenoldopam group while 73 among 366 in the control group were affected due to CIN. The risk ratio for the development of CIN in the Fenoldopam group was 1.19 compared to the control group. This was not statistically significant. Fenoldopam is no better than Placebo/Saline or NAC in preventing CIN, but more studies are required.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Clinical Imaging - Volume 39, Issue 5, September–October 2015, Pages 759–764
Journal: Clinical Imaging - Volume 39, Issue 5, September–October 2015, Pages 759–764
نویسندگان
Muhammad Naeem, Gregory E. McEnteggart, Timothy P. Murphy, Ethan Prince, Sun Ahn, Gregory Soares,